Usually, out-of-frame mutations result in the total absence of the protein and lead to DMD, the most severe form of dystrophinopathy, while in frame mutations that can determine partial, reduced or localized absence of dystrophin lead to more benign forms [8]. The gene discussed is DMD; the disease is neuromuscular disease caused by qualitative or quantitative defects of dystrophin.